Technimark Acquires Rage Custom Plastics for Healthcare Growth

Technimark, a prominent global player in custom injection-molded components, has significantly expanded its capabilities within the lucrative healthcare sector through the strategic acquisition of Rage Custom Plastics. This move, announced on March 16, 2026, marks a pivotal step for Technimark, particularly as it represents the first add-on acquisition since Oak Hill Capital and Pritzker Private Capital took ownership.

The integration of Rage Custom Plastics, a 65-year-old family-run enterprise with a strong legacy in blow and injection molding for medical and consumer health applications, is poised to amplify Technimark's market penetration. The transaction not only broadens Technimark's domestic manufacturing presence into the vital Mid-West and Mid-Atlantic regions of the United States but also crucially enhances its value-added blow molding services, a capability increasingly sought after in the medical device supply chain.

The healthcare plastics market, a segment experiencing robust growth driven by an aging global population and advancements in medical technology, presents a fertile ground for such strategic consolidations. Industry analysts project continued expansion in this sector, with demand for specialized, high-precision plastic components for everything from diagnostic equipment to drug delivery systems. Technimark's acquisition of Rage Custom Plastics positions it to capitalize on these trends more effectively.

Rage Custom Plastics, headquartered in Hilliard, Ohio, with additional facilities in Lewis Center, Ohio, Hurt, Virginia, and Altavista, Virginia, brings a wealth of experience and established customer relationships. Its 65-year track record underscores a commitment to quality and customer service, aligning with Technimark's own operational ethos. This synergy is expected to foster seamless integration and unlock new opportunities for both entities.

Dan Saliaris, the outgoing CEO of Rage Custom Plastics, expressed optimism about the future, stating, "Technimark's values, culture, and long-term vision mirror our own, and they bring capabilities and global scale that will create tremendous opportunity for our employees and customers." This sentiment highlights the cultural alignment that often proves critical in successful M&A activities.

Kris Peavy, Technimark's Chief Commercial Officer and President of Healthcare, further elaborated on the strategic rationale. "Rage's talented team, strong culture, and long-term partnerships with strategic healthcare customers make them a perfect acquisition for us," Peavy commented. "Their Mid-West and Mid-Atlantic operations further extend our domestic manufacturing capabilities, and their proficiency in blow molding enhances our full-service offering to customers." This expansion of manufacturing footprint and technical expertise is key to serving the evolving needs of the healthcare industry.

This strategic move by Technimark, backed by its private equity sponsors Oak Hill Capital and Pritzker Private Capital, underscores a clear strategy to consolidate and enhance its position in high-demand manufacturing sectors. The undisclosed financial terms of the deal reflect the strategic importance rather than a specific valuation metric at this stage.